For (NYSE:CRH), longer-horizon discussion often connects to sustained infrastructure renewal needs, portfolio actions, and operating discipline across cycles. Short-horizon moves, by contrast, can ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel immuno-oncology ...

Q4 2025 Earnings Call February 23, 2026 2:00 AM ESTCompany ParticipantsPeter Duffy - CEO & DirectorNiall McBride - CFO ...

St. James’s Place PLC (LON:SJP) posted an underlying cash result of £462.3 million for 2025, up 3% from £447.2 million in ...

Dr. Anczukow is a leading cancer biologist with expertise in RNA biology, molecular and cell biology, as well as human genetics, cancer biology, and genomics Olga Anczukow, Ph.D. Olga Anczukow, Ph.D.

Immunocore reports fourth quarter and full year 2025 financial results and provides a business update KIMMTRAK (tebentafusp-tebn) Q4 net sales of $104.5 million and $400.0 million for full year 2025; ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharma company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today its ...

Seneca recently issued its 1000 th Siemens mechatronics and automation certificate, becoming the first postsecondary institution in Canada to do so. This accomplishment highlights the shared ...

Jeff Vaughn says it was a 2022 billboard that convinced him being White and male was becoming a liability.

Quick lube sees a growth opportunity for preventative maintenance amid a buoyant market for M&A; many suppliers ...

The Carillon Chartwell Real Income Fund led its peer group in 2025 amid easing inflation and strong commodity performance. Read the full analysis for more details.